Last week's BioPharma Asia 2010 meeting, held in Singapore, saw the launch of the Pan-Asian Clinical Research Association (PACRA), which aims to promote clinical research training and continuing professional development for clinical researchers across Asia (from the Middle-East through to Japan), reports eCliniqua. The PACRA will provide a focal point throughout Asia for clinical research professionals.
'The concept for PACRA emerged from the realization that there is no existing focal point in Asia for clinical research professionals. This gave us reason enough to develop an Asian based and Asian focused organization entirely dedicated to the training and education of clinical research professionals across Asia,' said PACRA chairman Steve Bukvicin a press release. The organization is headed by a board of directors with a team of regional directors representing the Middle East, the Indian Subcontinent, Southeast Asia, North Asia, and Japan.
The crux of the PACRA's mission is education, which will include e-learning, instructor-led education, a PACRA conference and roundtable focus groups. The non-profit membership organization will ultimately offer standardized training to enhance professional development as well as the potential for opening up new career pathways in clinical research. The PACRA's main objectives are to keep members current with best practices, ensure training is up to date, develop clinical research careers and offer a hub for clinical researchers in this region. Membership in PACRA is currently open to anyone who is involved directly or indirectly in clinical research in Asia.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze